Participants characteristics and baseline
vomiting
ADVERSE EVENT
A total of 205 subjects were screened, of which 125 failed in screening for not meeting the inclusion criteria/for meeting exclusion criteria. Among the 80 qualified subjects, there were 40 in the fasting group and 40 in the fed group. In the fed trial, 2 subjects withdrew early. Among them, Subject S107 (C001) voluntarily withdrew early from the trial during the washout period after completing the first period of blood sample collection; and subject S152 (C021) voluntarily withdrew early from the trial 4.5 h after the first period of dosing. In the fasting trial, one subject voluntarily withdrew early. Subject S082 (K033) withdrew early from the trial due to an adverse event of severe vomiting with high volume, which occurred 1.75 h after the second period of dosing. The baseline characteristics of the subjects are shown in Table Summary of demography and its baseline characteristicsData are Mean ± SD